FONAR Stock Dips Post FY25 Earnings on Lower Profit and Higher Costs
FONR reports higher costs and lower profits in fiscal 2025, despite increases in scan volumes and imaging service revenues.
Zacks·23d ago
More News
FONAR's Stock Advances 5% in Three Months: Key Trends Ahead
FONR leverages hybrid MRI tech and a strong balance sheet to navigate industry headwinds, though rising costs and regulatory risks tied to claim collections remain key challenges.
Zacks·1mo ago
The Zacks Analyst Blog Highlights SAP SE, Novo Nordisk, Thermo Fisher Scientific and FONAR
SAP, NVO, TMO and FONR navigate growth and headwinds as analysts spotlight cloud momentum, obesity drugs, and innovation plays.
Zacks·3mo ago
Top Research Reports for SAP, Novo Nordisk & Thermo Fisher
SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.
Zacks·3mo ago
FONR Stock Rises Following Q3 Earnings on Higher Net Income
Zacks·5mo ago
Fonar Announces Six Months and 2nd Quarter Financial Results for Fiscal 2024
Total MRI scan volume at the HMCA-managed sites increased 13% to 101,990 scans for the six months ending December 31, 2023 versus the corresponding period one year earlier. Cash and cash equivalents...